Treating shingles after it appears doesn't reduce increased stroke risk
(American Heart Association) Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2019 Category: International Medicine & Public Health Source Type: news
Liver Cancer Recurrence Not Linked to Hepatitis Treatment Liver Cancer Recurrence Not Linked to Hepatitis Treatment
Patients with liver cancer related to hepatitis C infection should be considered for antiviral therapy with direct-acting antiviral therapies, say researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Direct-acting antivirals for chronic hepatitis C: risk of hypoglycaemia in patients with diabetes
Medicines and Healthcare products Regulatory Agency(MHRA) has issued a safety alert advising to monitor glucose levels closely in patients with diabetes during direct-acting antiviral therapy for hepa (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 21, 2018 Category: Drugs & Pharmacology Source Type: news
Option Found for Retreatment of Chronic Hep C Infection
THURSDAY, Nov. 15, 2018 -- Combined treatment with glecaprevir and pibrentasvir (G/P) is highly effective in treating chronic hepatitis C virus (HCV) genotype-1 infections that failed to respond to direct-acting antiviral therapy, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2018 Category: Pharmaceuticals Source Type: news
Hepatitis C Treatment Options: 5 Direct Questions
An HCV-infected patient who still injects drugs wants to start direct-acting antiviral therapy. What do guidelines recommend? (Source: ConsultantLive)
Source: ConsultantLive - November 14, 2018 Category: Internal Medicine Authors: Andrew Bowser Tags: Hepatitis C Source Type: news
HCV-Infected Kidney Waitlist Patients: Treat Now or Later? HCV-Infected Kidney Waitlist Patients: Treat Now or Later?
Which factors should be considered in the decision to initiate early or deferred direct-acting antiviral therapy among HCV-positive waitlisted patients?American Journal of Transplantation (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 1, 2018 Category: Surgery Tags: Nephrology Journal Article Source Type: news
Direct-acting antiviral therapy for hepatitis C saves costs in Italy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2018 Category: Drugs & Pharmacology Source Type: news
Eight Weeks of Antiviral Therapy for Recent HCV Infection Eight Weeks of Antiviral Therapy for Recent HCV Infection
Is an 8-week therapy of paritaprevir/ritonavir/ombitasvir and dasabuvir + ribavirin as effective as the standard 12-week regimen in individuals with recent HCV infection?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Preemptive DAAs for HCV+ Donor Livers Found Cost Effective
(MedPage Today) -- Direct-acting antiviral therapy in seronegative liver recipients could shorten transplant waiting lists (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 24, 2018 Category: Gastroenterology Source Type: news
